ææ°ã® Eli Lilly and Co ã®æ ªåŒãã¥ãŒã¹ã決ç®ãã¢ããªã¹ãè©äŸ¡ãéèŠãªååã远跡ã§ããŸãã
11æ5æ¥ã®Amgen Inc (AMGN) çµå€ã¯3.80%äžèœïŒäž»ãªæšé²èŠå ãæããã«ãããŸãã
11æ5æ¥ã®Eli Lilly and Co (LLY) çµå€ã¯3.55%äžèœïŒå€åãã®èåŸã«ããäºå®
11æ5æ¥ã®Gilead Sciences Inc (GILD) å€åãã¯3.61%äžèœïŒå€åãã®èåŸã«ããèŠå
11æ4æ¥ã®AbbVie Inc (ABBV) çµå€ã¯3.09%äžæïŒæè³å®¶ãç¥ã£ãŠããã¹ãæ å ±
11æ4æ¥ã®Merck & Co Inc (MRK) çµå€ã¯3.93%äžæïŒå€åãã®èåŸã«ããäºå®
11æ4æ¥ã®Johnson & Johnson (JNJ) å€åãã¯3.54%äžæïŒå€åãã®èåŸã«ããèŠå
11æ4æ¥ã®Novartis AG (NVS) å€åãã¯3.34%äžæïŒå®å šãªåæ
11æ3æ¥ã®Merck & Co Inc (MRK) å€åãã¯3.02%äžèœïŒã©ã®ãããªã·ã°ãã«ã瀺ããŠããã®ãïŒ
11æ3æ¥ã®Vertex Pharmaceuticals Inc (VRTX) å€åãã¯3.61%äžèœïŒå€åãã®èåŸã«ããèŠå
10æ30æ¥ã®Gilead Sciences Inc (GILD) å€åãã¯3.83%äžæïŒäž»ãªæšé²èŠå ãæããã«ãããŸãã